By Dietrich Knauth NEW YORK, May 1 (Reuters) - Purdue Pharma said on Friday that it has ceased operations and concluded its ...
Purdue Pharma secured court approval for a $125 million settlement with McKinsey & Co. to resolve claims related to the ...
A federal judge criminally sentenced OxyContin-maker Purdue Pharma over its role in the opioid crisis, ahead of upcoming ...
Shutting down Purdue Pharma and replacing it with the nonprofit Knoa Pharma was perhaps the most innovative aspect of ...
May 1 marks the first payment of billions to try to address ongoing harms from the overdose crisis.
Nearly 140,000 people filed claims against the company for the harm they said its drugs caused. Fewer than half of them will get any compensation.
NEW YORK, April 9 (Reuters) - Consulting firm McKinsey & Co has agreed to contribute $125 million to Purdue Pharma's bankruptcy settlement, resolving potential legal claims over advice it provided ‌to ...
Days before Purdue Pharma’s opioid settlement payouts are set to begin, more than 40% of claims have been rejected under tightened documentation rules. The revised $7.4 billion bankruptcy plan ...